Non-BRCA1/2 Variants Detected in a High-Risk Chilean Cohort With a History of Breast and/or Ovarian Cancer
Author(s) -
Christina Adaniel,
F. Beau Salinas,
Juan Manuel Donaire,
María Eugenia Bravo,
O Peralta,
Hernando Romero Paredes,
Nuvia Aliaga,
A. Guerrero Sola,
Paulieira,
Carolina Behnke,
Tulio E. Rodriguez,
Soledad Torres,
Francisco López,
Claudia Hurtado
Publication year - 2019
Publication title -
journal of global oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.002
H-Index - 17
ISSN - 2378-9506
DOI - 10.1200/jgo.18.00163
Subject(s) - genetic testing , penetrance , medicine , ovarian cancer , breast cancer , genetic predisposition , family history , germline mutation , germline , oncology , cancer , population , palb2 , gynecology , mutation , genetics , gene , biology , disease , phenotype , environmental health
Data were retrospectively collected from the registry of the High-Risk Breast and Ovarian Cancer Program at Clínica Las Condes, Santiago, Chile. Data captured included index case diagnosis, ancestry, family history, and genetic test results.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom